As an element of Nautilus’ overall reagent development and sourcing strategy, the partnership aims to accelerate research and development, and provide customers with access to Abcam’s antibody development technology and expertise SEATTLE and CAMBRIDGE, United Kingdom — Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the […]
MENLO PARK, Calif. and HONG KONG — PacBio will be providing its high-quality, highly accurate sequencing platforms to Prenetics Group Limited, a leading global genomics and diagnostic testing company, as the firm adds more comprehensive genetic screening services including carrier screening and cancer-risk screening in Hong Kong, Southeast Asia and in the United Kingdom. “With […]
BOSTON — BrickBio, the leader in site-specific bioconjugation, announced a rapid next-generation conjugation chemistry, eCLIC™ that will complement its existing high-performance chemistry, and may show significantly enhanced efficiency and scalability in a broad number of modalities across both proteins made in BrickBio’s mammalian and bacterial platforms. BrickBio has developed its flagship genomic expansion methodologies, utilizing […]
Technology increases the amount and quality of data that can be efficiently and cost-effectively obtained from a small DNA sample Manufacturing of the first product from a new technology platform is underway with expected commercial availability in early 2022; early access programs with renowned research institutions are ongoing CAMBRIDGE, United Kingdom — Cambridge Epigenetix (CEGX), […]
KKR to support Biosynth Carbosynth with organic and inorganic growth across geographies, best-in-class products and R&D innovation London and Staad – KKR, a leading global investment firm, and Biosynth Carbosynth, a leading life sciences reagents and custom synthesis and manufacturing services company, announce today that KKR has agreed to acquire Biosynth Carbosynth from Armira and CEO […]
BOULDER, Colo. — SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced a strategic collaboration with one of the nation’s leading academic medical centers, University Hospitals Cleveland Medical Center, where they will evaluate the impact of the company’s SomaSignal™ tests on the medical management of diabetic patients who are at a higher risk […]
icIEF-MS accelerates biotherapeutic development through identification of charge variants at the intact protein level FRAMINGHAM, Mass. — SCIEX, a global leader in life science analytical technologies, builds a new category of analytical instrumentation with icIEF-MS. Built in collaboration with customer partnerships, this new technology is part of the journey to help scientists close the developability gap. […]
New bioinformatic workflow advances analysis capabilities for whole exome assessment and interpretation BOSTON and LAUSANNE, Switzerland — SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine, announced today they have extended their SOPHiA DDM™ Universal Whole Exome analytical capabilities to include industry leading exome SureSelect Human All […]
QINGDAO, China — MGI Tech Co., Ltd. (MGI), a global life science leader and innovator, introduced a series of performance upgrades for its gene sequencing platforms* and a new multiplex PCR platform at the 16th International Conference on Genomics (ICG-16) held in Qingdao, China. As one of the three companies worldwide with the ability to mass-produce clinical high-throughput sequencers, MGI […]
DONGGUAN, China — Fapon Biotech Inc. (The Company or “Fapon Biotech”) is pleased to announce its full acquisition of Sequlite Genomics (“Sequlite”), a USA enterprise that focuses on Next-Generation Sequencing (“NGS”). The two parties have signed a share purchase agreement online, with the Fapon Biotech team in Dongguan headquarter and Sequlite team in the USA. […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
